Anti-Obesity Medications

The Booming Market for Anti-Obesity Medications: Opportunities and Challenges

The market for anti-obesity medications is experiencing unprecedented growth, with some analysts estimating it could become a $100 billion industry by the end of the decade. This surge is largely driven by the popularity of GLP-1 receptor agonists, such as Ozempic and Wegovy, which have shown remarkable efficacy in weight loss. Companies like Calibrate, Ro, …

The Booming Market for Anti-Obesity Medications: Opportunities and Challenges Read More »